| AI & Technology Virtual Investor Conference Agenda Announced for April 23rd |
Globe Newswire |
04/20 |
08:35 |
| Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing |
Globe Newswire |
04/20 |
08:35 |
| INVESTOR DEADLINE: Trip.com Group (TCOM) Investors with Substantial Losses Have Opportunity to Lead the Trip.com Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:33 |
| INVESTOR NOTICE: ODDITY Tech. (ODD) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/20 |
08:33 |
| Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026 |
Globe Newswire |
04/20 |
08:32 |
| INVESTOR NOTICE: Soleno Therapeutics (SLNO) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action – Hagens Berman |
Globe Newswire |
04/20 |
08:30 |
| 1847 Holdings Subsidiary Wolo Receives Approval of Amazon Brand Registry, Expanding E-Commerce Presence |
Globe Newswire |
04/20 |
08:30 |
| When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech |
Globe Newswire |
04/20 |
08:30 |
| Anthony, Linder & Cacomanolis Releases Strategic Analysis on PayPay IPO; Transaction Solidifies "Japan Corridor" to U.S. Capital Markets |
Globe Newswire |
04/20 |
08:30 |
| From Ukraine to the Middle East, GPS Disruption Drives Demand for Next-Generation Defense Technology |
Globe Newswire |
04/20 |
08:30 |
| INVESTOR DEADLINE: Eos Energy (EOSE) Investors with Substantial Losses Have Opportunity to Lead the Eos Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:27 |
| INVESTOR DEADLINE: Driven Brands (DRVN) Investors with Substantial Losses Have Opportunity to Lead the Driven Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:26 |
| Turbo Energy and Hithium Partner to Integrate AI-Driven Energy Optimization Software Into Battery Storage Systems Across Europe and Latin America |
Globe Newswire |
04/20 |
08:20 |
| INVESTOR DEADLINE: Apollo Global Management (APO) Investors with Substantial Losses Have Opportunity to Lead the Apollo Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:18 |
| Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions |
Globe Newswire |
04/20 |
08:15 |
| Bitcoin Casino No Deposit Bonus 2026: BitStarz Launches 50 Free Spins No Deposit Bonus with Instant Withdrawals |
Globe Newswire |
04/20 |
08:08 |
| YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026 |
Globe Newswire |
04/20 |
08:07 |
| dLocal Limited Announces Dismissal of New York State Securities Class Action |
Globe Newswire |
04/20 |
08:05 |
| Safe Pro Reports on Share Repurchase Program, Reinforcing Commitment to Shareholder Value and Capital Return |
Globe Newswire |
04/20 |
08:02 |
| Fiserv to Release First Quarter Earnings Results on May 5, 2026 and Confirms Details for May 14, 2026 Investor Day |
Globe Newswire |
04/20 |
08:01 |
| Global Uranium Completes Phase 1 Earn-In at Astro Project and Secures Initial 20% Interest |
Globe Newswire |
04/20 |
08:00 |
| COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations |
Globe Newswire |
04/20 |
08:00 |
| Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks |
Globe Newswire |
04/20 |
08:00 |
| Enlight to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026 |
Globe Newswire |
04/20 |
08:00 |
| Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026 |
Globe Newswire |
04/20 |
08:00 |
